These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 12888583)

  • 1. Bactericidal activity of levofloxacin against Mycoplasma pneumoniae.
    Duffy LB; Crabb DM; Bing X; Waites KB
    J Antimicrob Chemother; 2003 Sep; 52(3):527-8. PubMed ID: 12888583
    [No Abstract]   [Full Text] [Related]  

  • 2. Macrolide-resistant Mycoplasma pneumoniae in adults with community-acquired pneumonia.
    Miyashita N; Oka M; ; Kawai Y; Yamaguchi T; Ouchi K
    Int J Antimicrob Agents; 2010 Oct; 36(4):384-5. PubMed ID: 20674283
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro activity of the new quinolone derivative RD-3 against clinical isolates of Mycoplasma pneumoniae and Mycoplasma hominis.
    Sainath Rao S; Raghunathan M
    J Antimicrob Chemother; 2009 Dec; 64(6):1336-8. PubMed ID: 19850565
    [No Abstract]   [Full Text] [Related]  

  • 4. Experimental and clinical studies of sparfloxacin in Mycoplasma pneumoniae infection.
    Kaku M; Ishida K; Kohno S; Koga H; Hara K; Usui T
    Drugs; 1995; 49 Suppl 2():412-3. PubMed ID: 8549381
    [No Abstract]   [Full Text] [Related]  

  • 5. Emergence of macrolide-resistant Mycoplasma pneumoniae with a 23S rRNA gene mutation.
    Morozumi M; Hasegawa K; Kobayashi R; Inoue N; Iwata S; Kuroki H; Kawamura N; Nakayama E; Tajima T; Shimizu K; Ubukata K
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2302-6. PubMed ID: 15917525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of midecamycin diacetate against Mycoplasma pneumoniae and Chlamydia pneumoniae.
    Pereyre S; de Barbeyrac B; Renaudin H; Poutiers F; Bébéar C; Bébéar CM
    J Antimicrob Chemother; 2001 Feb; 47(2):240-1. PubMed ID: 11157917
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro and in vivo activities of sparfloxacin against Mycoplasma pneumoniae.
    Kaku M; Ishida K; Irifune K; Mizukane R; Takemura H; Yoshida R; Tanaka H; Usui T; Tomono K; Suyama N
    Antimicrob Agents Chemother; 1994 Apr; 38(4):738-41. PubMed ID: 8031039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of Garenoxacin against Macrolide-Susceptible and -Resistant Mycoplasma pneumoniae.
    Yamazaki T; Sasaki T; Takahata M
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2278-9. PubMed ID: 17387152
    [No Abstract]   [Full Text] [Related]  

  • 9. Mycoplasma pneumoniae isolated from patients with respiratory infection in Kanagawa Prefecture in 1976-2006: emergence of macrolide-resistant strains.
    Okazaki N; Ohya H; Sasaki T
    Jpn J Infect Dis; 2007 Sep; 60(5):325-6. PubMed ID: 17881881
    [No Abstract]   [Full Text] [Related]  

  • 10. In vitro activity of a new quinoline derivative, ER-2, against clinical isolates of Mycoplasma pneumoniae and Mycoplasma hominis.
    Rao SS; Raghunathan R; Ekambaram R; Raghunathan M
    Antimicrob Agents Chemother; 2009 Dec; 53(12):5317-8. PubMed ID: 19738013
    [No Abstract]   [Full Text] [Related]  

  • 11. Emerging macrolide resistance in Mycoplasma pneumoniae in children: detection and characterization of resistant isolates.
    Li X; Atkinson TP; Hagood J; Makris C; Duffy LB; Waites KB
    Pediatr Infect Dis J; 2009 Aug; 28(8):693-6. PubMed ID: 19633515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of macrolide-resistant Mycoplasma pneumoniae infection.
    Saegeman V; Proesmans M; Dumke R
    Pediatr Infect Dis J; 2012 Nov; 31(11):1210-1. PubMed ID: 22668803
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of in-vitro activities of SCH27899 and other antibiotics against Mycoplasma pneumoniae.
    Ikejima H; Yamamoto H; Ishida K; Terakubo S; Kaku M; Shimada J
    J Infect Chemother; 2001 Jun; 7(2):121-3. PubMed ID: 11455504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative antimicrobial activity of levofloxacin and ciprofloxacin against Streptococcus pneumoniae.
    Garrison MW
    J Antimicrob Chemother; 2003 Sep; 52(3):503-6. PubMed ID: 12917240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pharmacodynamic approach to antimicrobial activity in serum and epithelial lining fluid against in vivo-selected Streptococcus pneumoniae mutants and association with clinical failure in pneumonia.
    Alou L; Giménez MJ; Sevillano D; Aguilar L; Cafini F; Echeverría O; Pérez-Trallero E; Prieto J
    J Antimicrob Chemother; 2006 Aug; 58(2):349-58. PubMed ID: 16782744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis on antibacterial activity of common antibiotics to Mycoplasma pneumoniae].
    Xin DL; Chen XG; Han X
    Zhonghua Er Ke Za Zhi; 2009 Apr; 47(4):305-6. PubMed ID: 19555573
    [No Abstract]   [Full Text] [Related]  

  • 17. [Respiratory infections due to Mycoplasma pneumoniae].
    Bégué P; Lasfargues G; Omanga U
    Ann Pediatr (Paris); 1976 Jan; 23(1):43-6. PubMed ID: 16104250
    [No Abstract]   [Full Text] [Related]  

  • 18. Bactericidal activity of moxifloxacin against multidrug-resistant Streptoccocus pneumoniae at clinically achievable serum and epithelial lining fluid concentrations compared with three other antimicrobials.
    Cafini F; Alou L; Sevillano D; Valero E; Prieto J;
    Int J Antimicrob Agents; 2004 Oct; 24(4):334-8. PubMed ID: 15380257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative pharmacodynamics of the new fluoroquinolone ABT492 and levofloxacin with Streptococcus pneumoniae in an in vitro dynamic model.
    Firsov AA; Alferova IV; Smirnova MV; Lubenko IY; Portnoy YA; Zinner SH
    Int J Antimicrob Agents; 2005 May; 25(5):409-13. PubMed ID: 15848296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic options among broad-spectrum beta-lactams for infections caused by levofloxacin-nonsusceptible Streptococcus pneumoniae.
    Jones RN; Fritsche TR; Sader HS
    Diagn Microbiol Infect Dis; 2005 Jun; 52(2):129-33. PubMed ID: 15964501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.